Richard J. Morello

Form D signer

Richard J. Morello

President/CEO at CND Life Sciences

Form D signer

Capital raised by CND Life Sciences

$15.0M+$6.3M latest round

3 Form D filings · first filed Feb 2025

CURRENT ROLE: President/CEO
SECTOR: Healthcare
COMPANY FILINGS: 3
TEAM ON FILE: 2
FOUNDED: —
30D INTEREST: 2 ↗

Career

1 company on file

CND Life SciencesHealthcaresince Feb 2025

President/CEO

Signatory on CND Life Sciences's Form D filings · $15.0M raised across 3

Company filings

via EDGAR · Form D for CND Life Sciences3

DateCompanyFormAmountRole on filing

Jun 9, 2026CND Life SciencesForm D/A+$6.3MPresident/CEO

Form D/AJun 9, 2026 · CND Life Sciences+$6.3Mas President/CEO

Jun 9, 2026CND Life SciencesForm D+$4.3MPresident/CEO

Form DJun 9, 2026 · CND Life Sciences+$4.3Mas President/CEO

Feb 28, 2025CND Life SciencesForm D/A+$8.6MPresident/CEO

Form D/AFeb 28, 2025 · CND Life Sciences+$8.6Mas President/CEO

Overview

Last filing Jun 9, 2026

Richard J. Morello is on file as President/CEO at CND Life Sciences. CND Life Sciences has 3 Form D filings on record, $15.0M raised in total. Richard J. Morello appears as a signatory on the company's filings.

Teammates

CND Life Sciences · 1

Jack SeaverDirector

Products

CND Life Sciences · 1

Syn-One Test®Diagnostic Testing

The Syn-One Test® is a groundbreaking, minimally invasive diagnostic tool that detects and quantifies the presence of misfolded, phosphorylated alpha-synuclein in skin nerve fibers. This test is processed in a CLIA-certified and CAP-accredited laboratory through a straightforward procedure that requires three small skin biopsy samples.